HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Javier Díez Selected Research

Neoplasms (Cancer)

6/2022A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy.
1/2021Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer.
1/2021Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Javier Díez Research Topics

Disease

70Heart Failure
01/2024 - 08/2002
69Fibrosis (Cirrhosis)
01/2024 - 04/2002
37Hypertension (High Blood Pressure)
01/2023 - 05/2003
21Heart Diseases (Heart Disease)
01/2021 - 12/2002
16Atherosclerosis
01/2021 - 01/2005
11Hypertrophy
08/2012 - 03/2005
10Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2023 - 01/2004
10Inflammation (Inflammations)
01/2023 - 01/2005
9Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 04/2014
8Essential Hypertension
03/2014 - 01/2002
7Chronic Renal Insufficiency
05/2022 - 12/2005
6Left Ventricular Dysfunction
06/2022 - 04/2006
6Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 06/2004
5Type 2 Diabetes Mellitus (MODY)
01/2023 - 05/2012
5Obesity
03/2018 - 01/2005
4Pathologic Processes
11/2021 - 04/2005
4Atrial Fibrillation
01/2019 - 06/2006
4Prediabetic State (Prediabetes)
03/2018 - 03/2013
4Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2015 - 01/2006
4Insulin Resistance
12/2014 - 12/2008
3Neoplasms (Cancer)
06/2022 - 01/2021
3Systolic Heart Failure
10/2014 - 07/2006
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
09/2023 - 01/2021
2Diabetes Mellitus
12/2022 - 04/2017
2Breast Neoplasms (Breast Cancer)
06/2022 - 12/2008
2Ventricular Remodeling
01/2019 - 01/2018
2Abdominal Obesity
03/2018 - 01/2015
2Myocardial Infarction
11/2017 - 01/2014
2Diastolic Heart Failure
10/2017 - 07/2006
2Cardiomegaly (Heart Hypertrophy)
04/2015 - 10/2008
2Kidney Diseases (Kidney Disease)
11/2013 - 12/2010
2Ischemia
11/2012 - 02/2009
2Necrosis
11/2012 - 05/2012

Drug/Important Bio-Agent (IBA)

52Biomarkers (Surrogate Marker)IBA
10/2023 - 04/2002
44CollagenIBA
10/2023 - 05/2002
19NADPH Oxidases (NAD(P)H oxidase)IBA
04/2017 - 08/2004
17Collagen Type I (Type I Collagen)IBA
01/2023 - 11/2003
15Superoxides (Superoxide)IBA
04/2017 - 08/2004
14Procollagen Type IIBA
01/2023 - 04/2002
11CytokinesIBA
03/2014 - 03/2005
10Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2007
10Angiotensin IIIBA
11/2017 - 01/2002
9procollagen type I carboxy terminal peptide (PICP)IBA
01/2023 - 09/2007
8Peptides (Polypeptides)IBA
01/2023 - 08/2005
7Torsemide (Demadex)FDA LinkGeneric
01/2018 - 08/2002
6Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
01/2023 - 03/2004
6Brain Natriuretic Peptide (Natrecor)FDA Link
01/2021 - 03/2014
6Antihypertensive Agents (Antihypertensives)IBA
08/2010 - 12/2002
5Spironolactone (Aldactone)FDA LinkGeneric
12/2022 - 01/2018
5Matrix Metalloproteinases (MMPs)IBA
01/2021 - 03/2004
5Glucagon-Like Peptide 1 (GLP 1)IBA
01/2021 - 05/2012
5Furosemide (Lasix)FDA LinkGeneric
01/2018 - 08/2002
5EnzymesIBA
01/2017 - 03/2004
5Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2017 - 02/2009
5Insulin (Novolin)FDA Link
12/2014 - 01/2006
5Interleukin-6 (Interleukin 6)IBA
03/2014 - 11/2011
4Natriuretic PeptidesIBA
12/2022 - 02/2009
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 03/2013
4SaltsIBA
01/2019 - 04/2006
4Messenger RNA (mRNA)IBA
11/2017 - 10/2007
4MicroRNAs (MicroRNA)IBA
01/2017 - 02/2009
4Losartan (Cozaar)FDA LinkGeneric
01/2017 - 05/2002
4NADP (NADPH)IBA
09/2010 - 11/2004
3pro-brain natriuretic peptide (1-76)IBA
01/2022 - 02/2009
3Collagen Type III (Type III Collagen)IBA
01/2021 - 03/2014
3GadoliniumIBA
01/2021 - 08/2010
3AldosteroneIBA
01/2021 - 01/2004
3Troponin T (Troponin T1)IBA
01/2019 - 12/2016
3HDL CholesterolIBA
03/2018 - 01/2015
3Tissue Inhibitor of Metalloproteinase-1IBA
01/2016 - 06/2010
3Fibrillar CollagensIBA
08/2015 - 12/2002
3cardiotrophin 1IBA
03/2014 - 08/2012
3CalciumIBA
11/2012 - 05/2012
3LeptinIBA
09/2010 - 09/2002
3Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
08/2009 - 06/2004
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2008 - 12/2002
34- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
02/2008 - 05/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2007 - 11/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2007 - 07/2005
2Blood Glucose (Blood Sugar)IBA
03/2023 - 03/2013
2sacubitril and valsartan sodium hydrate drug combinationIBA
01/2023 - 01/2021
2Galectin 3 (LGALS3)IBA
01/2021 - 04/2015
2procollagen Type III-N-terminal peptide (PIIP)IBA
01/2021 - 04/2015
2CreatinineIBA
09/2017 - 03/2009
2Triglycerides (Triacylglycerol)IBA
04/2017 - 11/2015
2Connective Tissue Growth FactorIBA
01/2017 - 11/2013
22- butyl- 4- chloro- 1- ((2'- (1H- tetrazol- 5- yl)(1,1'- biphenyl)- 4- yl)methyl)- 1H- imidazole- 5- carboxaldehydeIBA
01/2017 - 10/2009
2OsteopontinIBA
01/2016 - 07/2013
2Uric Acid (Urate)IBA
11/2015 - 06/2006
2G-Protein-Coupled Receptor Kinase 2IBA
12/2014 - 10/2010
2Mitochondrial Permeability Transition PoreIBA
11/2012 - 05/2012
2Waste Products (Waste Product)IBA
11/2012 - 05/2012
2Oxygen (Dioxygen)IBA
11/2012 - 05/2012
2Free RadicalsIBA
11/2012 - 05/2012
2Annexin A5IBA
11/2011 - 11/2007
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2011 - 03/2006
2C-Reactive ProteinIBA
12/2010 - 04/2006

Therapy/Procedure

15Therapeutics
10/2023 - 02/2009
2Drug Therapy (Chemotherapy)
06/2022 - 01/2021
2Precision Medicine
03/2020 - 01/2018